Advances in Management of Diabetic Retinopathy
Featuring the P. Kenneth Nase Memorial Lecture by Judy Kim, MD
Saturday, May 22, 2021 / 8 A.M. - 12 P.M. ET
LIVE STREAM ONLY
Program Chairs:
Michael A. Klufas, MD and Ajay E. Kuriyan, MD
Description:
This conference will inform participants on the emerging practices across the various subspecialties that challenge conventional standards. The goal of this program is to review and discuss the current evidence that support or oppose these controversial topics.
At the conclusion of this educational activity, participants should be able to:
- Discuss important new advances in the etiologies, diagnosis, and treatment/prevention of eye diseases.
- Identify basic and clinical vision research that can be transformed into improved clinical care.
- Assess the role of new technologies in the evaluation and treatment of eye diseases.
- Describe factors that impact the effective delivery of the highest quality eye care for the public.
- Identify clinical, scientific, and ethical issues confronting the profession.
- Obtain information and tools through multiple facets to help ophthalmologists deliver high and efficient quality of care.
GUEST FACULTY
Judy Kim, MD
WILLS EYE FACULTY
Allen Chiang, MD
Michael N. Cohen, MD
Sunir J. Garg, MD
Omesh P. Gupta, MD
Jason Hsu, MD
M. Ali Khan, MD
Michael A. Klufas, MD
Ajay E. Kuriyan, MD
Sonia Mehta, MD
Jose Pulido, MD
Carl D. Regillo, MD
James F. Vander, MD
David Xu, MD
Yoshihiro Yonekawa, MD
Accreditation Statement
Wills Eye Hospital is accredited by the ACCME to provide continuing medical education to its physicians. Wills Eye Hospital designates this live educational activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
It is the policy of Wills Eye Hospital that the information presented at Wills Eye Hospital's CME activities will be unbiased and based on scientific and clinical evidence. To help participants make judgments about the presence of bias, Wills Eye Hospital will provide information that Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available on the website, in the activity Program/Proceedings, and is available for download.
Claiming CME Credit
Prior to the start of the activity, you should have an account on the new Knowledge Portal with an email address that you will have access to and a cellphone number linked to your account. If you do not have an account, please create one. Please also ensure to link your account to your cellphone number . At the time of the activity, you will receive an activity code. Text the activity code to (855) 959-3979. Once your attendance is recorded, you can complete an evaluation through your Knowledge Portal account. Learners will be automatically reminded of any outstanding evaluations. You may also view any outstanding evaluations on the Knowledge Portal under My CME. At the conclusion of the evaluation, you will receive a certificate via email that you can also reference at any time on your Knowledge Portal account to view, download or email. If you have any questions, please contact the Wills Eye Hospital Department of CME at 215.440.3169 or at cme@willseye.org.
Agenda
| 7:30 a.m. | Registration and Breakfast |
| 8 a.m. |
Introduction |
|
Diabetic Retinopathy Clinical Trials in 2021 |
| 8:04 a.m. | Phase 3 Faricimab Trials for Diabetic Retinopathy (DR) & Diabetic Macular Edema (DME) Carl D. Regillo, MD |
| 8:12 a.m. | Current Clinical trials for DR/DME at MAR/WillsEye Allen Chiang, MD |
| 8:20 a.m. | Impact of Race on Outcomes of Phase III Clinical Trials Evaluating Ranibizumab for DME M. Ali Khan, MD |
| 8:28 a.m. | Geographic Access Disparities to Clinical Trials in Diabetic Eye Disease in the USA Yoshihiro Yonekawa, MD |
| 8:35 a.m. | Introduction of Annual Nase Lecturer – Judy Kim, MD Carl D. Regillo, MD |
| 8:40 a.m. | How to Manage DR in 2021 Judy Kim, MD |
| 9:05 p.m. |
Break |
|
Surgical Retina |
|
| 9:15 a.m. | When to Perform Early PPV in Diabetic Patients Omesh P. Gupta, MD |
| 9:23 a.m. | Internal Limiting Membrane (ILM) Peeling for Persistent DME Sonia Mehta, MD |
| 9:31 a.m. | Surgery for Proliferative Diabetic Retinopathy (PDR): Pearls & Pitfalls David Xu, MD |
| 9:40 a.m. | Surgical Retina Case Presentations Moderator: David Xu, MD Panel: James Vander, MD; Sonia Mehta, MD; Omesh Gupta, MD; Sunir Garg, MD |
| 10:10 p.m. |
Break |
| 10:05 p.m. |
Medical Retina/Imaging |
| 10:25 a.m. | Syndromic Diabetic Diseases and the Eye Jose Pulido, MD |
| 10:33 a.m. | Loss to Follow-Up After Intravitreal Anti-VEGF Injections for DME Jason Hsu, MD |
| 10:41 a.m. | OCTA in DR & DME Michael N. Cohen, MD |
| 10:49 a.m. | Ultra-Widefield Imaging in DR Michael A. Klufas, MD |
| 10:57 a.m. | Fluctuations in Central Subfield Thickness Associated with Worse Visual Outcomes in Patients with Diabetic Macular Edema in Clinical Trial Settings Ajay E. Kuriyan, MD |
| 11:05 a.m. | Medical Retina Case Presentations Moderator: Michael Cohen, MD Panel: Jose Pulido, MD; Judy Kim, MD; Jason Hsu, MD; Ajay E. Kuriyan, MD |
| 11:40 p.m. |
Questions and Answers |
| 12 p.m. |
Adjournment |